TCTAP A-103 Mechanisms of In-stent Restenosis in Hemodialysis Patients

Norihito Nakamura,Gaku Nakazawa,Shingo Matsumoto,Tsutomu Murakami,Toshiharu Fujii,Masataka Nakano,Yohei Ohno,Norihiko Shinozaki,Fuminobu Yoshimachi,Yuji Ikari

TCTAP A-103 Mechanisms of In-stent Restenosis in Hemodialysis Patients

2018

Norihito Nakamura
Gaku Nakazawa
Shingo Matsumoto
Tsutomu Murakami
Toshiharu Fujii
Masataka Nakano
Yohei Ohno
Norihiko Shinozaki
Fuminobu Yoshimachi
Yuji Ikari

It is well known that percutaneous coronary intervention in hemodialysis (HD) patients is associated with higher rates of in-stent restenosis (ISR) compared to non-HD patients. However, little is known about lesion morphologies that may contribute to ISR in this population. Therefore, this study

Keywords:

Percutaneous coronary intervention
Restenosis
Lesion
Cardiology
Population
Stent
Hemodialysis
Internal medicine
Diabetes mellitus
Medicine
in stent restenosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations